Combination drug therapy for low back pain
Referencias
Additional references
Attal N, Perrot S, Fermanian J, Bouhassira D. The neuropathic components of chronic low back pain: a prospective multicentre study using the DN4 questionnaire. The Journal of Pain 2011;12(10):1080‐7.
Boutron I, Moher D, Tugwell P, Giraudeau B, Poiraudeau S, Nizard R, et al. A checklist to evaluate a report of a non pharmacological trial (CLEAR NPT) was developed using consensus. Journal of Clinical Epidemiology 2005;58:1233‐40.
Chou R, Qaseem A, Snow V, Casey D, Cross TJ, Shekelle P, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Annals of Internal Medicine 2007;147(7):478‐91.
Duffy S, Misso K, Noake C, Ross J, Stirk L. Supplementary searches of PubMed to improve currency of MEDLINE and MEDLINE In‐Process searches via OvidSP. Kleijnen Systematic Reviews Ltd, York. Poster presented at the UK InterTASC Information Specialists' Sub‐Group (ISSG) Workshop; 9 July 2014; Exeter: UK (2014) [accessed 6 14]. Available from: https://medicine.exeter.ac.uk/media/universityofexeter/medicalschool/research/pentag/documents/Steven_Duffy_ISSG_Exeter_2014_poster_1.pdf.
Freynhagen R, Baron R, Gockel U, Tolle TR. PainDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Current Medical Research and Opinion 2006;22(10):1911‐20.
Furlan AD, Pennick V, Bombardier C, van Tulder M. 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009;34(18):1929‐41.
Gore M, Sadosky A, Stacey BR, Tai KS, Leslie D. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings. Spine 2012;37(11):E668‐77.
Guyatt GH, Oxman AD, Vist GE, Falck‐Ytter Y, Schunemann H. GRADE: What is "quality of evidence" and why is it important to clinicians?. BMJ 2008;336:995‐8.
Hall GC, Morant SV, Carroll D, Gabriel ZL, McQuay HJ. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Family Practice 2013;14:28.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011:Available from www.cochrane‐handbook.org.
Hoy D, March L, Brooks P, Blyth FM, Woolf A, Bain C, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Annals of the Rheumatic Diseases 2014;73:968‐74.
Koes B, van Tulder MW, Thomas S. Diagnosis and treatment of low back pain. BMJ 2006;332:1430‐4.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
Menezes Costa L da C, Maher CG, Hancock MJ, McAuley JH, Herbert RD, Costa LOP. The prognosis of acute and persistent low‐back pain: a meta‐analysis. Canadian Medical Association Journal 2012;184(11):E613‐E24.
Miranda H, Viikari‐Juntura E, Martikainen R, Takala E, Riihimaki H. Individual factors, occupational loading, and physical exercise as predictors of sciatic pain. Spine 2002;27(10):1102‐9.
Morlion B. Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components. Current Medical Research & Opinion 2011;27(1):11‐33.
Mueller PS, Montori VM, Bassler D, Koenig BA, Guyatt GH. Ethical issues in stopping randomized trials early because of apparent benefit. Ideas and Opinions 2007;146:878‐82.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Romano CL, Romano D, Lacerenza M. Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review. Pain Research and Treatment 2012;2012:154781.
Shell WE, Charuvastra EH, DeWood MA, May LA, Bullias DH, Silver DS. A double‐blind controlled trial of a single dose naproxen and an amino acid medical food theramine for the treatment of low back pain. American Journal of Therapeutics 2012;19(2):108‐14.
Stafford MA, Peng P, Hill DA. Sciatica: a review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management. British Journal of Anaesthesia 2007;99(4):461‐73.
Taylor‐Stokes G, Lobosco S, Pike J, Sadosky AB, Ross E. Relationship between patient‐reported chronic low back pain severity and medication resources. Clinical Therapeutics 2011;33(11):1739‐48.
Tubach F, Beauté J, Leclerc A. Natural history and prognostic indicators of sciatica. Journal of Clinical Epidemiology 2004;57(2):174‐9.
van Tulder M, Koes B, Bombardier C. Low back pain. Best Practice & Research Clinical Rheumatology 2002;16(5):761‐75.
van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 2003;28(12):1290‐9.
Vetter G, Bruggemann G, Lettko M, Schwieger G, Asbach H, Biermann W, et al. Results of a randomized double‐blind study, diclofenac 50 mg versus diclofenac 50 mg plus B vitamins, in painful spinal diseases with degenerative changes [German]. Zeitschrift für Rheumatologie 1988;47(5):351‐62.
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Oslo, Norway: Norwegian Institute of Public Health, 2013.
Williams CM, Maher C, Hancock M, McAuley J, McLachlan AJ, Britt H, et al. Low back pain and best practice care. Archives of Internal Medicine 2010;170(3):271‐7.
